Unknown

Dataset Information

Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors.


ABSTRACT: Aptamers are single-stranded DNA or RNA sequences that bind target molecules with high specificity and affinity. Aptamers exhibit several notable advantages over protein-based therapeutics. Aptamers are non-immunogenic, easier to synthesize and modify, and can bind targets with greater affinity. Due to these benefits, aptamers are considered a promising therapeutic candidate to treat various conditions, including hematological disorders and cancer. An active area of research involves developing aptamers to target blood coagulation factors. These aptamers have the potential to treat cardiovascular diseases, blood disorders, and cancers. Although no aptamers targeting blood coagulation factors have been approved for clinical use, several aptamers have been evaluated in clinical trials and ma

SUBMITTER: Liu M 

PROVIDER: S-EPMC8069679 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature